Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman(Newcastle University), Gordon W. Dewald(Mayo Clinic), Athena M. Cherry(Stanford Health Care), Rodney R. Higgins(Abbott Northwestern Hospital), Georgina Buck(MRC Clinical Trials Unit at UCL), Jacob M. Rowe(Technion – Israel Institute of Technology), Elisabeth Paietta(Montefiore Medical Center), Christine J. Harrison(Newcastle University), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Mark R. Litzow(Mayo Clinic in Arizona), Gail H. Vance(Indiana University Bloomington), Peter H. Wiernik(Albert Einstein College of Medicine), Anthony H. Goldstone(Royal London Hospital), Lorna M. Secker‐Walker(Blood Cancer UK), Sue Richards(Oregon Health & Science University), Mary Martineau(Blood Cancer UK), Adele K. Fielding(New York Blood Center), Letizia Foroni(Centre for Inflammation Research)
Cited by 746
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k